Enza biotech
Producing novel and biobased ingredients for the personal care and health care sectors.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (78 %) | 113 % | (81 %) | - | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | - | (8553 %) | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (196 %) | (1278 %) | (886 %) | (9148 %) | - | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Enza Biotech, now a part of Croda International Plc, is a pioneering company in the biotechnology sector. The company specializes in developing innovative surfactants, which are substances that help mix oil and water, making them essential in various products like detergents and cosmetics. Enza Biotech's unique technology, known as oligomeric alkyl glycosides, offers improved performance and reduced irritation compared to traditional surfactants. This technology was showcased at the Formula VIII conference, highlighting its potential in the market.
Enza Biotech operates in the biobased chemicals market, focusing on creating sustainable alternatives to fossil-based products. Their clients range from industrial manufacturers to consumer goods companies looking for eco-friendly ingredients. By leveraging their deep understanding of molecular science and biotechnology, Enza Biotech designs and produces novel molecules that address specific industrial challenges.
The company's business model revolves around research and development (R&D) and licensing their proprietary technology to larger corporations. This approach allows them to generate revenue through licensing fees and royalties. Additionally, Enza Biotech has received grants and funding, such as the 300,000 SEK from Vinnova, to support their innovative projects.
In summary, Enza Biotech is a small but highly innovative company that plays a crucial role in the transition to a biobased society. Their acquisition by Croda International is expected to further enhance their capabilities and market reach.
Keywords: biotechnology, surfactants, sustainable, oligomeric alkyl glycosides, eco-friendly, R&D, licensing, industrial, consumer goods, innovation.